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Abstract
Background: The physiopathology of dengue hemorrhagic fever (DHF), a severe form of Dengue Fever, is poorly
understood. We are unable to identify patients likely to progress to DHF for closer monitoring and early intervention during
epidemics, so most cases are sent home. This study explored whether patients with selected co-morbidities are at higher
risk of developing DHF.
Methods: A matched case-control study was conducted in a dengue sero-positive population in two Brazilian cities. For
each case of DHF, 7 sero-positive controls were selected. Cases and controls were interviewed and information collected on
demographic and socio-economic status, reported co-morbidities (diabetes, hypertension, allergy) and use of medication.
Conditional logistic regression was used to calculate the strength of the association between the co-morbidities and
occurrence of DHF.
Results: 170 cases of DHF and 1,175 controls were included. Significant associations were found between DHF and white
ethnicity (OR= 4.70; 2.17–10.20), high income (OR= 6.84; 4.09–11.43), high education (OR= 4.67; 2.35–9.27), reported
diabetes (OR= 2.75; 1.12–6.73) and reported allergy treated with steroids (OR = 2.94; 1.01–8.54). Black individuals who
reported being treated for hypertension had 13 times higher risk of DHF then black individuals reporting no hypertension.
Conclusions: This is the first study to find an association between DHF and diabetes, allergy and hypertension. Given the
high case fatality rate of DHF (1–5%), we believe that the evidence produced in this study, when confirmed in other studies,
suggests that screening criteria might be used to identify adult patients at a greater risk of developing DHF with a
recommendation that they remain under observation and monitoring in hospital.
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Introduction
Dengue is the most important viral vector-transmitted disease
worldwide in terms of the total number of cases, disease morbidity
and mortality [1]. This arboviral disease affects large areas of
countries in tropical and subtropical regions of the world. As the
physiopathology of the severe presentations, dengue hemorrhagic
fever (DHF)/Dengue Shock Syndrome (DSS), remains poorly
understood, there are no effective means to predict or prevent
progression to this severe clinical expression of the infection [2,3].
According to the World Health Organization (WHO) [4],
around 500,000 cases of DHF/DSS, occur annually, with 22,000
deaths. Until the 1980’s years, Southeast Asia was the region most
affected by dengue; then it spread to Central and South America
and now it is present from the 35th parallel north to the 35th
parallel south [2]. In Southeast Asia the incidence of DHF/DSS is
high and the disease typically affects mainly children [5]. Until
2007, the clinical pattern of dengue was very different in Brazil
(currently the country that reports most cases of dengue fever to
the WHO): the majority of cases had occurred among adults and
the percentage of the severe forms of the disease was low; but since
the 2008 epidemic in Rio de Janeiro, the risk of morbidity and
mortality due DHF/DSS began to rise in children [6,7].
It is not clear why some cases of dengue progress to DHF;
understanding this process is essential for preventing it. There is
evidence that sequential infections by different dengue viral
serotypes plays a important role [8]. However, even during
widespread epidemics of dengue fever, in populations with high
levels of antibodies against dengue virus (indicating a previous
infection), the proportion of cases that progress to DHF is small,
ranging from,0.5% to 4% of all cases [9,10] indicating that other
factors are involved in disease severity. Several hypotheses have
been raised but so far none supported by solid evidence. It has
been suggested that some preexisting chronic diseases such as
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diabetes, hypertension and bronchial asthma increase the risk of
progression to severe forms of dengue [11,12] based on case series
with no control group. The objective of the case-control study
reported here was to evaluate the contribution of comorbidities to
the development of DHF.
Methods
This is a matched case-control study carried out in two coastal
cities in the northeast of Brazil, Salvador and Fortaleza, with
populations of roughly two and a half million each. The minimal
sample size (159 cases and 636 controls) was determined to be able
to detect an increase of 2.3 fold in the risk of DHF in cases of
dengue who also had diabetes (prevalent in 7% of the controls, the
least common of comorbidities studied), with 95% precision, 80%
power and a ratio of at least 4 controls for each case. We
eventually studied 170 cases and 1,175 controls.
The study population consisted of subjects with a history of
dengue, confirmed serologically. Only cases and controls who
tested positive (IgG) for the anti-dengue antibodies were included
in the study, since we wanted to investigate reasons for progression
to DHF, not for infection with dengue virus. Cases were selected
among those notified with dengue hemorrhagic fever during the
period 2002 and 2003 in Salvador and 2003–2005 in Fortaleza. In
Salvador the research was conducted in 2004, while in Fortaleza, it
was conducted in 2005.
Selection of cases: Cases of DHF registered in the national
surveillance system (SINAN) in residents of these two cities
between 2003 and 2005 were identified as potential cases for the
study. Their surveillance records were examined by two physicians
and included in the study if they met the criteria for DHF used by
Brazilian Health Service [13] which is very similar to the WHO
[14]: (i) fever and positive serology for anti dengue virus IgM and/
or viral isolation and characterization by cell culture or RT-PCR
(ii) at least two signs or symptoms of dengue fever (headache or
retroorbital pain, myalgia, arthralgia, prostration, exanthema) and
(iii) all of the following signs: a) hemorrhagic manifestations (at
least one type); b) hemoconcentration with an increase of at least
10% in basal hematocrit level (in 80% of the selected cases the
increase was 20% or greater, in 13% between 12 and 18% and in
7% between 10 and 12%) and/or hematocrit values .38% in the
case of a child, .40% in the case of an adult female and .45% in
the case of an adult male; c) thrombocytopenia (#100,000/mm3).
We did not consider ascites, pleural effusion, as these were very
rarely recorded in the SINAN at the time. In Salvador, of the 91
cases of DHF notified to SINAN, 26 did not meet the criteria and
were not included in the study and 65 met the criteria and were
invited to participate in the study; 55 agreed to participate. No
deaths from DHF were recorded during the study period. In
Fortaleza, 194 cases of DHF were notified to SINAN, 55 did not
meet the criteria and 139 were invited to participate in the study.
Of these 5 had died from others causes since the notification, and
19 refused to participate. The remaining 115 were included in the
study. Cases which were excluded had severe dengue but did not
meet the criteria for DHF or their records did not have sufficient
information.
For each case, a pool of 7–8 potential controls were selected
from individuals living in the neighborhood of each case,
according to a rule (from the first case on either side of the case’s
residence, until a suitable control was found, limited to the block)
matched by sex and age (within five years), and who reported
dengue fever in the same year as the case. Blood was drawn from
the pool of potential controls by venous puncture for exclusion of
those without seropositivity for dengue. The serum was separated
by centrifugation and stored at 220uC. The Department of
Arbovirology and Hemorrhagic Fevers of the Evandro Chagas
Institute performed ELISA for anti-dengue IgG antibodies, with
titers were above 1:40 [15] being considered positive. 64 potential
controls (5.2%) did not have anti-dengue IgG antibodies titers
above 1:40 and were excluded from the study. 1,175 controls
remained in the study.
Cases and controls were interviewed (during 2005–2006) at
home by teams of trained interviewers using a previously tested,
standardized questionnaire, collecting the following types of
information: demographic and biological (name, address, age,
sex), socio economic (years of schooling, family income expressed
as a multiple of the legal minimum salary (US$120 a month at the
time of the interview) and self-reported skin color. Clinical
information collected included signs and symptoms of dengue
and reported morbidity with respect to diabetes, hypertension,
allergy, asthma, kidney failure, liver failure and sickle-cell anemia
at the time of the reported dengue, and use of medication for these
illnesses at the moment of the interview. When the individual
reported having had one of these conditions, he/she was asked
whether the diagnosis had been made by a doctor and the
interviewer asked to see the prescription and/or packaging of any
medication. To avoid bias, interviewers were blind to the study
objectives and all field work was supervised.
Analysis: To reduce the data, cases and controls were grouped
according to their biological and social characteristics and the
frequency of self-reported chronic diseases. Reported kidney
failure, liver failure and sickle-cell anemia were not considered
in this analysis because they were either not reported or reported
by very few cases or controls.
The crude association (OR and 95%CI) between the predictors
of interest, presence of co-morbidities (hypertension, diabetes,
allergy and asthma) and outcome of interest, presence of DHF was
investigated using cross tabulations based on matched pair
analysis, the McNemar’s test [16] (since this was a matched
study). Adjusted measures for the association were estimated using
multivariate logistic regression adjusting for potential confounding
variables. As this was a matched case control study using
individual matching, conditional logistic regression was used to
estimate the association between the predictors of interest
Author Summary
Dengue is an arboviral disease that affects large areas of
countries in tropical and subtropical regions of the world.
Around 500,000 cases and 22,000 deaths of dengue
hemorrhagic fever (DHF)/Dengue Shock Syndrome (DSS),
the most severe presentations of this disease, occur
annually. It is unclear why some cases of dengue fever
(0.5% to 4%) progress to DHF/DSS. There is weak evidence
that some diseases could have a role in this process, such
as diabetes, hypertension, and allergies. In epidemics most
dengue fever cases are sent home as there are too many to
be kept in observation, but if it were possible to identify
those with a higher risk of progression to DHF, they could
be kept for observation, for early detection of signs,
symptoms and alterations in laboratory tests suggestive of
DHF, to enable timely and effective clinical management
and early intervention. We study this issue and we believe
that the evidence produced in this study, when confirmed
in other studies, suggests that screening criteria might be
used to identify adult patients at a greater risk of
developing DHF with a recommendation that they remain
under observation and monitoring in a hospital.
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(independent variables: hypertension, diabetes, allergy and
asthma) and the occurrence of DHF (dependent variable: presence
or absence of DHF) within each matched set of case and controls.
Since the study was matched for age, sex, neighborhood and city,
the conditional logistic regression adjusted for these variables as
potential confounders. To establish whether skin color, schooling
and income were also potential confounding variables, we
explored the association between these variables and DHF. The
subsequent regression models exploring the association between
comorbidities and DHF included those variables as potential
confounders. A separate model was built for each of the co-
morbidities of interest and also for each co-morbidity stratified by
number and type of drug used. We did not include a model with
all co- morbidities because we did not have sufficient power. Since
black skin color has been reported to be a protective factor against
DHF [17,18], and is also known to be associated with
hypertension [12], a specific analysis was carried out on cases
and controls who described themselves as being black. The
STATAH software program, version 9, was used to perform data
processing and analysis.
Ethical approval was granted by the Research Ethics Commit-
tee, Instituto de Sau´de Coletiva, Federal University of Bahia,
Salvador, Brazil. Cases and controls who agreed to participate in
the study gave written informed consent.
Results
Of the 170 cases of DHF included in the study, 55.9% were
women and around 80% occurred in individuals over 15 years of
age. With respect to skin color, 43.5% of cases considered
themselves white, 50.0% mixed race and 6.5% black. Over 51% of
cases had 11 years or more of schooling and 47.1% had an income
of at least four minimum salaries. Of the 1,175 controls, 54.6%
were female, 80.9% were over 15 years of age; 27.1% considered
themselves white, 64.5% mixed race and 8.4% black; 31.5% had
11 years or more of schooling; and 17.5% had an income of at
least 4 minimum salaries. Of these demographic variables,
statistically significant differences (p,0.05) were found between
the two groups only with respect to skin color, years of schooling
and family income. Statistically significant differences (p,0.05)
were also found between the cases and controls with respect to self-
reported diabetes and allergy (Table 1).Skin color, schooling, and
income were all independently associated with DHF. The
likelihood (crude, matched OR) of a white individual having been
affected by DHF was 4.60 times higher than that of a black
participant. Family income $4 minimum salaries (OR = 7.02) and
$11 years of schooling (OR = 4.66) were also found to be risk
factors for this clinical form of dengue. There was little variation in
the values of these measurements of association following
adjustment for chronic diseases, differences remaining statistically
significant (Table 2).
When each one of the self-reported chronic diseases was
adjusted for the ethnic and social variables, only diabetes remained
associated with DHF (adjusted OR = 2.75; 95% CI: 1.12–6.73)
(Table 3).
When the self-reported diseases were classified according to use
of the respective medications, with the category ‘‘absence of
disease’’ as reference, the use of medication (steroids and no
steroids) by allergic individuals was found to be positively
associated with DHF; however, following adjustment for the
ethnic and social variables, the association was maintained only for
allergy treated with steroids (OR = 2.94; 95%CI: 1.01–8.54). Of
the individuals who reported hypertension, an increasing gradient
was found in the crude and adjusted OR when the use of
medication was considered (no treatment, treatment with only one
antihypertensive drug or treatment with more than one hyper-
tensive drug); however, these differences were not statistically
significant (Table 4).
In the subgroup analysis of the cases and controls who described
themselves as black, the individuals who had hypertension and
used more than one antihypertensive medication were found to
have a 13-fold greater likelihood of having DHF (95%CI: 1.42–
118.8) compared to black individuals who did not have
hypertension. Black individuals with hypertension who did not
use medication or who used only one type of antihypertensive
medication were around four times more likely to have had DHF
when compared to black individuals without hypertension;
however, this difference was not statistically significant(data not
shown on tables).
Table 1. Distribution of Socio-demographic characteristic
and morbidities conditions by cases (DHF) and controls (DF).
Exposure Cases (n = 170)
Controls
(n = 1,175) p value
Nu % Nu %
Sex
Male 75 44.1 534 45.4
Female 95 55.9 641 54.6 0.74
Age
#15 years 35 20.6 224 19.1
$16 years 135 79.4 951 80.9 0.64
Skin colour
Black 11 6.5 99 8.4
Mixed 85 50.0 758 64.5 0.01
White 74 43.5 318 27.1
Schooling (years of study)
#3 19 11.1 210 17.9
4–7 27 15.9 333 28.3 0.01
8–10 37 21.8 263 22.3
$11 87 51.2 369 31.5
Income (minimum salary)
#1 38 22.4 471 40.1
2–3 52 30.5 498 42.4 0.01
$4 80 47.1 206 17.5
Hypertension
Yes 20 11.8 148 12.6
No 150 88.2 1,027 87.4 0.75
Diabetes
Yes 09 5.3 31 2.6
No 161 94.7 1,144 97.4 0.05
Allergy
Yes 58 34.1 279 23.4
No 112 65.9 896 76.3 0.04
Asthma
Yes 10 5.9 62 5.3
No 160 94.1 1,113 94.7 0.74
DHF – Dengue hemorrhagic fever.
DF – Dengue fever.
doi:10.1371/journal.pntd.0000699.t001
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Discussion
The results of this study showed that individuals who reported
having allergies (and for which they used steroids), or those who
reported diabetes, were two and a half times as likely to have
DHF. DHF is known to be more common in repeat dengue
infections. Current knowledge about the physiopathology of DHF
suggests amplification of the immune response due to the presence
of heterotypic antibodies against a serotype of the dengue virus at
the time of new infection [8,11] as an explanation for the higher
frequency of DHF in repeat dengue infections. The immune
system in allergic individuals may be persistently activated with
signs of inflammation in tissues and capillaries [19,20], and if we
consider the use of steroids for allergy as a marker of the severity of
the allergy, one can conclude that severe allergy is even more likely
to lead to inflammation and liberation of pro inflammatory
cytokines in tissues, particularly in the endothelium. An alternative
explanation for this finding might be that steroid use itself may
increase risk of DHF since they can produce capillary fragility.
The inflammation hypothesis is consistent also with the increased
risk with diabetes. Type II diabetes, a metabolic disorder of adults
that reduces the use of glucose by the organism, changes the
anatomical and physiological integrity of the endothelium due to a
permanent inflammatory condition caused by activation of T-
lymphocytes. This process leads to the release of pro-inflammatory
cytokines such as gamma interferon (IFNy) and TNFa [21,22].
These cytokines are known to have a fundamental role in one of
the main phenomena responsible for the clinical manifestations of
DHF, the third space fluid shift [23], which is a consequence of
endothelial dysfunction and results in hemoconcentration, hypo-
tension and shock. It would appears that triggering endothelial
dysfunction may be the common biological mechanism by which
allergy and diabetes increase the risk of progression to DHF, by
increasing the intrinsic permeability of the endothelial surface of
hosts who have been previously infected by another serotype,
permitting the occurrence of fluid shift.
Although no statistically significant association was found
between hypertension and DHF, it is interesting that when
individuals without hypertension were taken as a reference group,
a clear trend was found for an increased likelihood of DHF among
those who reported having hypertension but did not use any
antihypertensive medication followed by hypertensive individuals
who used more than one antihypertensive drug. On the other
hand, the thirteen-fold higher association between individuals who
consider themselves black and use an antihypertensive drug and
DHF, when compared with non-hypertensive black individuals,
strengthens the hypothesis that preexisting diseases in which
physiopathology detrimentally affects endothelial function may
help trigger the phenomenon of fluid shift resulting from the
increased vascular permeability that characterizes DHF.
The increase in DHF in subjects with white skin color is well
described [11,17] and recent in vivo study associated these
Table 2. Crude and adjusted* Odds Ratio of the association
of Dengue Hemorrhagic Fever with skin colour, schooling and
income.
Exposure
OR
crude 95% CI
OR
adjusted 95% CI
Skin colour
Black 1 1 1 1
Mixed 1.88 0.91–3.89 1.96 0.94–4.10
White 4.60 2.13–9.90 4.70 2.17–10.20
Schooling
#3 years 1 1 1 1
4–7 years 1.07 0.55–2.08 1.09 0.55–2.15
8–10 years 2.35 1.17–4.74 2.45 1.20–4.99
$11 years 4.66 2.37–9.15 4.67 2.35–9.27
Income (minimum salary)
#1 1 1 1 1
2–3 1.70 1.06–2.72 1.70 1.06–2.72
$4 7.02 4.21–11.6 6.84 4.09–11.43
*Adjusted Odds Ratio were obtained from a multivariate conditional logistic
regression with skin color, schooling, and income being adjusted by selected
self-reported chronic conditions.
doi:10.1371/journal.pntd.0000699.t002
Table 3. Crude and adjusted* Odds Ratio of the association of Dengue Hemorrhagic Fever with chronic co-morbidities.
Exposure Cases Controls Matched OR crude** 95% CI OR Adjust 95% CI
Hypertension
No 150 1,027 1 1
Yes 20 148 0.90 0.50–1.62 0.93 0.51–1.70
Diabetes
No 161 1,144 1 1
Yes 9 31 2.46 1.03–5.87 2.75 1.12–6.73
Allergy
No 112 896 1 1
Yes 58 279 1.59 1.11–2.28 1.29 0.87–1.89
Asthma
No 160 1,113 1 1
Yes 10 62 0.93 0.46–1.89 0.87 0.41–1.84
*Adjusted Odds Ratio were obtained from a multivariate conditional logistic regression with hypertension, diabetes, allergy, and asthma being adjusted by selected self-
reported skin color, income and education.
**Matched OR and 95 CI calculated using McNemar’s test.
doi:10.1371/journal.pntd.0000699.t003
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differences with genetic markers of African ancestry [18]. In the
cities where the study was conducted the proportion of individuals
of African descent (black and mixed) is over 68%, the majority
belonging to a lower socioeconomic stratum than the white
population, with lower family income and poorer education [24].
The greater likelihood of DHF in white individuals with higher
education levels and higher family income is consistent with both a
mixed ancestry subjects being more likely to call themselves white
if they are rich and well educated or the presence of some other
undetected lifestyle factors associated with an increase the risk of
DHF.
The growth in the frequency of allergic and atopic diseases that
has been observed in recent decades has emphasized the need for
research studies capable of explaining the mechanisms involved in
this phenomenon. Changes in lifestyle, initially in countries of
Eastern Europe, have occurred in parallel with a growth in the
rate of asthma and other allergic diseases [25,26,27]. There is
evidence that individuals living in cleaner environments, who are
consequently less exposed to infections, are at a greater risk of
developing allergic diseases (‘‘the hygiene hypothesis’’). Although
this hypothesis has been controversial, there evidence that some
infections early in life may protect individuals against allergic and
atopic diseases years later [28,29]. It is therefore feasible to
speculate that white individuals with higher education levels and
family income, who in this study were found to have a 7-fold
greater risk of having been affected by DHF, would also constitute
the segment of the population with the highest risk of suffering
from allergies or of having higher levels of allergic sensitization,
which may act as triggers of the mechanisms of amplification of
the immune response. This hypothesis should be the object of new
studies designed to clarify the issue.
This study was retrospective, based on reported co-morbidities,
and a self-reported date of history of dengue fever in controls. The
diagnosis of DHF was based on the information from review of
cases investigated by the surveillance system. These potential
limitations create methodological concerns. However, to be
included in this analyses, available hospital data was reviewed by
experts and found to satisfy the clinical and laboratory criteria
described in Methods. To increase the validity of reported co-
morbidities and medication, the investigators requested to see
medical prescriptions and drug packaging to ensure that the
information obtained indirectly was as reliable. The data collection
procedures were standardized and identical for the two compar-
ison groups.
A potential bias in this study is that dengue infection rates varied
in Salvador and Fortaleza by skin color. However, there is good
evidence that skin colour is not associated with dengue infection
[30]. As to likelihood that a diagnosis and notification of DHF
varies by skin color, this is also very unlikely because Brazil has
universal health care free at the point of use. As for notifications of
cases to health authorities by provider, is known that private health
providers less often notify cases to National Health Service than
public sector provider. This would tend to introduce a bias toward
cases reported among lower incoming and black patients.
Subgroup analysis in blacks had not been planned. We
hypothesized that hypertension was a risk and we knew of course
that hypertension is more common in blacks. We did the subgroup
analysis because hypertension risk was not found to be a risk factor
in the role patient population. We suggest a cautious interpretation
of this finding but urge that this be investigated in future studies.
We did not present results separately for the two cities. This is
appropriate as matching for cities would have controlled for any
confounding; it would not have been appropriate if the
associations between co-morbidities and DHF were different in
the two cities. We did examine the magnitude of the associations in
the two cities and judged them to be similar.
The exclusion of individuals who were seronegative under the
sample constraints described assured that all cases and controls,
Table 4. Crude and adjusted* Odds Ratio of the association of Dengue Hemorrhagic Fever with chronic co-morbidities stratified
by number or type of drugs used.
Exposure Cases Controls Matched OR crude** 95% CI OR Adjust 95% CI
No hypertension 150 1,027 1 1 1 1
Hypertension no drugs 04 57 0.48 0.16 1.38 0.50 0.16 1.49
Hypertension with 1drug 08 55 0.95 0.39 2.27 0.97 0.39 2.41
Hypertension with .1 drug 08 36 1.76 0.74 4.19 1.67 0.68 4.09
No diabetes 161 1,144 1 1 1 1
Diabetes no drugs 01 07 1.55 0.18 13.3 1.83 0.18 18.67
Diabetes 1 drug 05 15 2.32 0.74 7.24 2.72 0.86 8.60
Diabetes with insulin or more than 1 drug 09 03 3.53 0.83 14.9 3.36 0.72 15.61
No allergy 112 896 1 1
Allergy no drugs 44 235 1.46 0.98 2.16 1.16 0.76 1.77
Allergy drugs anti allergic 08 27 1.90 0.80 4.55 1.45 0.58 3.61
Allergy drugs steroids 06 17 2.79 1.05 7.44 2.94 1.01 8.54
No Asthma 160 1,113 1 1
Asthma no drugs 05 42 0.63 0.23 1.67 0.60 0.21 1.66
Asthma drug no steroids 04 12 2.29 0.72 7.26 2.13 0.63 7.21
Asthma drug with steroids 01 08 0.71 0.84 5.96 0.60 0.05 6.28
*Adjusted Odds Ratio were obtained from a multivariate conditional logistic regression with hypertension, diabetes, allergy, and asthma being adjusted by selected self-
reported skin color, income and education.
**Matched OR and 95 CI calculated using McNemar’s test.
doi:10.1371/journal.pntd.0000699.t004
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had dengue infection in the past. DENV1 and DENV2 have been
circulating intensely in the two cities since the 1990s and the
populations of these cities have high levels of antibodies against
these serotypes [31,32]. Most cases of DHF included in this study
were caused by DENV3, which was introduced into these cities
only in 2002 [10]. Because this is a retrospective study, we do not
know the date of or number of dengue infections in control. It is
possible that many individuals were infected prior to 2005 or 2006.
It is important to emphasize that controls reported having had a
dengue like illness during the same period of the matched case and
reported never having had DHF.
This is the first case-control study to investigate the association
between hospitalization with a diagnosis of DHF and evidence of
diabetes and allergy, and hypertension and the results reported
here are the initial evidence for this very important association. In
dengue epidemics most dengue fever cases are seen in out-patients
settings and then sent home, as there are too many for all to be
hospitalized for observation, in spite of the potential for
progression to DHF. If it were possible to identify those with
higher risk of progression to DHF, and to keep them for
observation, for to early detection of signs, symptoms and
alterations in laboratory tests suggestive of DHF, this would
enable timely and effective clinical management. Early interven-
tion is such cases will reduce mortality substantially, since the case
fatality rate of DHF in SE Asian patients is high (1–5%). We
believe the evidence produced in this study when confirmed
suggests that screening criteria might be used to identify adult
patients at a greater risk of developing DHF with a recommen-
dation that they remain under observation and monitoring in
hospital. We also recommend further clinical studies to define new
protocols on the evolution of dengue infections in patients with
diabetes, allergies and hypertension (particularly with respect to
drugs used) and appropriate medical management. Finally, cross
immunologic pathophysiologic studies based on the associations
between diabetes, allergy and high socioeconomic status and
DHF, are urgently needed to investigate the intricate mechanism
controlling severe forms of dengue.
Supporting Information
Checklist S1 STROBE checklist.
Found at: doi:10.1371/journal.pntd.0000699.s001 (0.20 MB
RTF)
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